معرفی
Qi Hu is a Casual Academic in the College of Science and Engineering at Flinders University, concurrently pursuing PhD studies. His primary institutional affiliations include the Flinders Institute for Nanoscale Science and Technology and the Medical Device Research Institute.
He obtained his Master's degree from Flinders University's College of Science and Engineering in 2020. His research centers on developing advanced biosensing technologies for biomedical applications.
Dr. Hu's research program focuses on biomarker detection and monitoring using fluorescence strategies based on aggregation-induced emission (AIE). His work spans metamaterials and metasurfaces, fluorescence/chemi-luminescence/bio-luminescence techniques, and vortex fluidic device applications. This interdisciplinary approach bridges biomedical engineering, optical physics, and clinical diagnostics.
Analysis of his publication trends reveals strong concentration in optical biosensor development, particularly for albumin detection and orthopedic implant monitoring. His work shows increasing emphasis on point-of-care diagnostic platforms and integration of nanomaterials with fluidic systems.
His research contributes to UN Sustainable Development Goals related to good health and well-being through advanced diagnostic technologies.
Dr. Hu collaborates extensively with researchers across biomedical engineering, with notable partnerships in nanoscale science and medical device development. His work has attracted media attention with coverage by 5 news outlets and discussion across social media platforms.
He maintains active laboratory work within the Flinders Institute for Nanoscale Science and Technology, focusing on the development of novel biosensing platforms using aggregation-induced emission phenomena and vortex fluidic technologies.
